SoHum Living Soils to Appear at Denver Cannagrow Expo
DENVER, CO - 
(NewMediaWire) - October 27, 2016 - American Cannabis Company, Inc. (
SoHum Living Soils™ is a proprietary "just add water" growing medium that contains 100% natural ingredients and provides the plant a full buffet of macro/micro nutrients to achieve genetic optimization of the cannabis plant. Not only do SoHum Living Soils™ optimize the plant's potential, it also eliminates both the need for complex feeding schedules as well as the associated risk(s) of operator error. SoHum Living Soils™ utilize the geoponic cultivation methodology, growing the plant in soil just as nature intended. The SoHum Living Soils™ product overview may be viewed at goo.gl/Vr0pqs.
Corey Hollister, President and CEO of American Cannabis Company, Inc. commented: "Cannabis operators are now moving on from the practice of measuring success strictly based on product yield to evaluating success based on traditional business metrics such as quality, cost of goods sold and output versus input. SoHum Living Soils™ are built to meet the needs of the developing industry as it matures."
About American Cannabis Company, Inc. American Cannabis Company, Inc. offers end-to-end solutions to existing and aspiring participants in the cannabis industry. We utilize our industry expertise to provide business planning and market assessment services, assist state licensing procurement, create business infrastructure and implement operational best practices. American Cannabis Company also developed and owns a portfolio of branded products including: The patented Satchel™, SoHum Living Soils™, The Cultivation Cube™ and The High Density Cultivation System™. In addition, we design and provide other industry specific custom product solutions. The building and development of our brands and product suite is based on our Geoponics Philosophy, "the art and science of agriculture in soil."
For more information, please visit: www.americancannabiscompanyinc.com www.sohumsoils.com
Forward Looking Statements This news release contains "forward-looking statements" which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as "anticipate", "seek", intend", "believe", "estimate", "expect", "project", "plan", or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company's reliance on existing regulations regarding the use and development of cannabis-based drugs. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.
